Management of diabetes mellitus in patients with chronic kidney disease
- PMID: 28702221
- PMCID: PMC5469199
- DOI: 10.1186/s40842-015-0001-9
Management of diabetes mellitus in patients with chronic kidney disease
Abstract
Glycemic control is essential to delay or prevent the onset of diabetic kidney disease. There are a number of glucose-lowering medications available but only a fraction of them can be used safely in chronic kidney disease and many of them need an adjustment in dosing. The ideal target hemoglobin A1c is approximately 7 % but this target is adjusted based on the needs of the patient. Diabetes control should be optimized for each individual patient, with measures to reduce diabetes-related complications and minimize adverse events. Overall care of diabetes necessitates attention to multiple aspects, including reducing the risk of cardiovascular disease, and often, multidisciplinary care is needed.
Keywords: Chronic kidney disease; Diabetes; Diabetic kidney disease; Glycemic control; Hemoglobin A1c; Nephropathy.
References
-
- ADA Microvascular complications and foot care. Sec. 9. In standards of medical care in diabetes - 2015. Diabetes Care. 2015;38:S58–66. - PubMed
-
- KDOQI (Kidney Disease Outcomes Quality Initiative). Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12–154. - PubMed
-
- ADA Glycemic targets. Sec. 6. In standards of medical care in diabetes - 2015. Diabetes Care. 2015;38:S33–40. - PubMed
-
- Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013;19:327–36. - PubMed
-
- KDOQI (Kidney Disease Outcomes Quality Initiative). Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012, 60:850–886. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources